日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The Safety Data of Dupilumab for the Treatment of Moderate‑to‑Severe Atopic Dermatitis in Infants, Children, Adolescents, and Adults

Dupilumab治疗婴幼儿、儿童、青少年和成人中重度特应性皮炎的安全性数据

Langley, Richard G; Gherardi, Guy; Coleman, Anna; Ardeleanu, Marius; Rodríguez-Marco, Ainara; Levy, Stephane; Bansal, Ashish; Chen, Zhen; Rossi, Ana B; Shumel, Brad; Khokhar, Faisal A

One-Year Insights into the GLOBOSTAD Multinational Prospective Observational Study of Patients Receiving Dupilumab for Atopic Dermatitis

GLOBOSTAD 多国前瞻性观察研究一年期结果:接受度普利尤单抗治疗的特应性皮炎患者研究

Calzavara-Pinton, Piergiacomo; Chu, Chia-Yu; Lapeere, Hilde; Rossi, Mariateresa; Ferrucci, Silvia M; Chung, Wen-Hung; Fougerousse, Anne-Claire; Fomina, Daria S; Holzer, Gregor; Čelakovská, Jarmila; Al-Ahmad, Mona; Tzellos, Thrasyvoulos; Wu, Jiangming; Ardeleanu, Marius; Bosman, Kwinten

Systemic Treatments in Moderate-to-Severe Atopic Dermatitis in Pediatric Patients up to 12 Years of Age: Real-World Treatment Outcomes from the PEDISTAD Registry

针对12岁以下中重度特应性皮炎患儿的系统性治疗:来自PEDISTAD注册研究的真实世界治疗结果

Paller, Amy S; Marcoux, Danielle; Ramien, Michele; Baselga, Eulalia; Carvalho, Vania Oliveira; Ardusso, Ledit R F; de Graaf, Marlies; Pasmans, Suzanne; Toledo-Bahena, Mirna; Rubin, Cory; Joyce, Joel C; Lee, Lara Wine; Gupta, Rajan; Adams, Bryan; Ardeleanu, Marius; Zhang, Annie

Immunogenicity of dupilumab in adult and pediatric patients with atopic dermatitis

度普利尤单抗在成人和儿童特应性皮炎患者中的免疫原性

Kamal, Mohamed A; Kosloski, Matthew P; Lai, Ching-Ha; Partridge, Michael A; Rajadhyaksha, Manoj; Kanamaluru, Vanaja; Bansal, Ashish; Shabbir, Arsalan; Shumel, Brad; Ardeleanu, Marius; Richards, Susan M; Yan, Hong; Xu, Christine R; Rodríguez-Marco, Ainara; Xiao, Jing; Khokhar, Faisal A; Gherardi, Guy; Babilonia, Elisa; Maloney, Jennifer; Mortensen, Eric; Akinlade, Bolanle; Braunstein, Ned; Stahl, Neil; Torri, Albert; Davis, John D; DiCioccio, A Thomas

Correlation Analysis of Clinician- and Patient-Reported Outcomes Among Japanese Adults with Atopic Dermatitis

日本成人特应性皮炎患者临床医生报告结局与患者报告结局的相关性分析

Saeki, Hidehisa; Kataoka, Yoko; Etoh, Takafumi; Katoh, Norito; Teramukai, Satoshi; Tajima, Yuki; Fujita, Hiroyuki; Ardeleanu, Marius; Arima, Kazuhiko

Pathophysiology of Bullous Pemphigoid: Role of Type 2 Inflammation and Emerging Treatment Strategies (Narrative Review)

大疱性类天疱疮的病理生理学:2型炎症的作用及新兴治疗策略(叙述性综述)

Werth, Victoria P; Murrell, Dédée F; Joly, Pascal; Heck, Renata; Orengo, Jamie M; Ardeleanu, Marius; Hultsch, Verena

Baseline Demographics, Comorbidities, Treatment Patterns and Burden of Atopic Dermatitis in Adults and Adolescents from the GLOBOSTAD Long-Term Observational Study

GLOBOSTAD长期观察研究中成人和青少年特应性皮炎患者的基线人口统计学特征、合并症、治疗模式和疾病负担

Calzavara-Pinton, Piergiacomo; Čelakovská, Jarmila; Lapeere, Hilde; Holzer, Gregor; Al-Ahmad, Mona; Chu, Chia-Yu; Ferrucci, Silvia M; Kataoka, Yoko; Rossi, Mariateresa; Fomina, Daria S; Chung, Wen-Hung; Tzellos, Thrasyvoulos; Fougerousse, Anne-Claire; Wu, Jiangming; Ardeleanu, Marius; Ozturk, Zafer E

Phytomediated-Assisted Preparation of Cerium Oxide Nanoparticles Using Plant Extracts and Assessment of Their Structural and Optical Properties

利用植物提取物辅助制备二氧化铈纳米粒子及其结构和光学特性的评估

Nicusor Fifere, Anton Airinei, Florica Doroftei, Tudor Stefan Ardeleanu, Marius Dobromir, Daniel Tîmpu, Elena-Laura Ursu

Consistency of Response to Dupilumab in Adults with Moderate-to-Severe Atopic Dermatitis Over 1 Year

年后,中重度特应性皮炎成人患者对度普利尤单抗治疗的疗效一致性

Blauvelt, Andrew; de Bruin-Weller, Marjolein; Simpson, Eric L; Chen, Zhen; Ardeleanu, Marius; Rossi, Ana B

Baseline Demographics and Severity and Burden of Atopic Dermatitis in Adult Patients Initiating Dupilumab Treatment in a Real-World Registry (PROSE)

真实世界注册研究 (PROSE) 中接受度普利尤单抗治疗的成年患者的基线人口统计学特征、特应性皮炎的严重程度和疾病负担

Bagel, Jerry; Nguyen, Tien Q; Lima, Hermenio; Jain, Neal; Pariser, David M; Hsu, Sylvia; Yosipovitch, Gil; Zhang, Haixin; Chao, Jingdong; Bansal, Shikha; Chen, Zhen; Richman, Daniel; Korotzer, Andrew; Ardeleanu, Marius